These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10864054)

  • 1. Growth factor practice patterns among pediatric oncologists: results of a 1998 Pediatric Oncology Group Survey. Economic Evaluation Working Group the Pediatric Oncology Group.
    Parsons SK; Mayer DK; Alexander SW; Xu R; Land V; Laver J
    J Pediatr Hematol Oncol; 2000; 22(3):227-41. PubMed ID: 10864054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Smith TJ; Weeks JC; Bredt AB; Feinglass J; Fetting JH; Hillner BE; Somerfield MR; Winn RJ
    J Clin Oncol; 1996 Sep; 14(9):2511-20. PubMed ID: 8823330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Weeks JA; Somerfield MR; Feinglass J; Smith TJ
    J Clin Oncol; 1999 Nov; 17(11):3676-81. PubMed ID: 10550166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current clinical practice in the treatment of febrile neutropenia (FN)].
    Takei N; Komatsu T
    Jpn J Antibiot; 2011 Oct; 64(5):293-310. PubMed ID: 22428213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA.
    Freifeld A; Sankaranarayanan J; Ullrich F; Sun J
    Support Care Cancer; 2008 Feb; 16(2):181-91. PubMed ID: 17943327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a survey on practices in onco-hematology in France in 2001].
    Cordonnier C; Magnier C; Leverger G; Ghanassia JP; Herbrech R;
    Presse Med; 2004 Mar; 33(5):324-6. PubMed ID: 15041883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.
    Haeusler GM; Slavin MA; Bryant PA; Babl FE; Mechinaud F; Thursky KA
    J Paediatr Child Health; 2018 Jul; 54(7):761-769. PubMed ID: 29655245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Bishop MR; Tallman MS; Somerfield MR; Feinglass J; Smith TJ
    Ann Oncol; 1999 Nov; 10(11):1355-9. PubMed ID: 10631465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The practice patterns of adult oncologists' care of pediatric oncology patients.
    Brady AM; Harvey C
    Cancer; 1993 May; 71(10 Suppl):3237-40. PubMed ID: 8490860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
    Adams JR; Elting LS; Lyman GH; George JN; Lembersky BC; Armitage JO; Demetri GD; Bennett CL
    Am J Med; 2004 Jan; 116(1):28-34. PubMed ID: 14706663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists.
    Henderson TO; Hlubocky FJ; Wroblewski KE; Diller L; Daugherty CK
    J Clin Oncol; 2010 Feb; 28(5):878-83. PubMed ID: 20038717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
    Aapro MS; Bohlius J; Cameron DA; Dal Lago L; Donnelly JP; Kearney N; Lyman GH; Pettengell R; Tjan-Heijnen VC; Walewski J; Weber DC; Zielinski C;
    Eur J Cancer; 2011 Jan; 47(1):8-32. PubMed ID: 21095116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Survey of Oncologists' Perceptions and Opinions Regarding the Use of Granulocyte Colony-Stimulating Factors.
    Hawkins A; Murphy A; McNamara M; Gawade PL; Belani R; Kelsh MA
    J Cancer Educ; 2020 Feb; 35(1):178-186. PubMed ID: 31656028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunisation practices of paediatric oncology and shared care oncology consultants: a United Kingdom survey.
    Bate J; Patel SR; Chisholm J; Heath PT;
    Pediatr Blood Cancer; 2010 Jul; 54(7):941-6. PubMed ID: 20162684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.
    J Clin Oncol; 1994 Nov; 12(11):2471-508. PubMed ID: 7964965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncology nurses' use of National Comprehensive Cancer Network clinical practice guidelines for chemotherapy-induced and febrile neutropenia.
    Nirenberg A; Reame NK; Cato KD; Larson EL
    Oncol Nurs Forum; 2010 Nov; 37(6):765-73. PubMed ID: 21059588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of granulocyte colony-stimulating factor: a survey among Italian medical oncologists.
    Danova M; Rosti G; De Placido S; Bencardino K; Venturini M
    Oncol Rep; 2005 Dec; 14(6):1405-12. PubMed ID: 16273232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
    Timmer-Bonte JN; Adang EM; Termeer E; Severens JL; Tjan-Heijnen VC
    J Clin Oncol; 2008 Jan; 26(2):290-6. PubMed ID: 18182670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza immunization practices among pediatric oncologists.
    Porter CC; Poehling KA; Hamilton R; Frangoul H; Cooper WO
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):134-8. PubMed ID: 12571465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.